blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0351921

EP0351921 - Modified beta adrenergic receptor [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  10.08.1994
Database last updated on 19.07.2024
Most recent event   Tooltip10.08.1994Application deemed to be withdrawnpublished on 28.09.1994 [1994/39]
Applicant(s)For all designated states
Merck & Co., Inc.
126, East Lincoln Avenue P.O. Box 2000 Rahway
New Jersey 07065-0900 / US
[N/P]
Former [1990/04]For all designated states
MERCK & CO. INC.
126, East Lincoln Avenue P.O. Box 2000
Rahway New Jersey 07065-0900 / US
Inventor(s)01 / Dixon, Richard A. F.
758 Hartley Drive
Lansdale, PA 19446 / US
02 / Patchett, Arthur A.
1090 Minisink Way
Westfield New Jersey 07090 / US
03 / Sigal, Irving S.
deceased / US
04 / Strader, Catherine D.
119 Morningside Road
Verona New Jersey 07044 / US
[1990/04]
Representative(s)Cole, William Gwyn, et al
European Patent Department
Merck & Co., Inc.
Terlings Park
Eastwick Road
Harlow, Essex CM20 2QR / GB
[N/P]
Former [1993/20]Cole, William Gwyn, et al
European Patent Department Merck & Co., Inc. Terlings Park Eastwick Road
Harlow Essex CM20 2QR / GB
Former [1990/04]Hesketh, Alan, Dr.
European Patent Department Merck & Co., Inc. Terlings Park Eastwick Road
Harlow Essex, CM20 2QR / GB
Application number, filing date89201885.419.07.1989
[1990/04]
Priority number, dateUS1988022318222.07.1988         Original published format: US 223182
[1990/04]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP0351921
Date:24.01.1990
Language:EN
[1990/04]
Type: A3 Search report 
No.:EP0351921
Date:17.07.1991
Language:EN
[1991/29]
Search report(s)(Supplementary) European search report - dispatched on:EP28.05.1991
ClassificationIPC:A01K67/00, C12N15/85
[1990/04]
CPC:
C12N15/8509 (EP); A01K67/00 (EP); C07K14/70571 (EP);
C12N15/85 (EP); A01K2217/05 (EP); A01K2227/10 (EP);
A01K2227/105 (EP); A01K2227/30 (EP); A01K2267/02 (EP);
C12N2830/008 (EP) (-)
Designated contracting statesCH,   DE,   FR,   GB,   IT,   LI,   NL [1990/04]
TitleGerman:Modifizierter beta-adrenergischer Rezeptor[1990/04]
English:Modified beta adrenergic receptor[1990/04]
French:Récepteur bêta adrénergique modifié[1990/04]
File destroyed:15.01.2000
Examination procedure11.12.1991Examination requested  [1992/06]
24.09.1993Despatch of a communication from the examining division (Time limit: M06)
06.04.1994Application deemed to be withdrawn, date of legal effect  [1994/39]
05.05.1994Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [1994/39]
Fees paidRenewal fee
13.06.1991Renewal fee patent year 03
28.07.1992Renewal fee patent year 04
20.07.1993Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[YD]  - NATURE, vol. 326, 5th March 1987, pages 73-77; R.A.F. DIXON et al.: "Ligand binding to the beta-adrenergic receptor involves its rhodopsin-like core"
 [Y]  - TRENDS IN BIOTECHNOLOGY, vol. 5, no. 1, January 1987, pages 13-19, Amsterdam, NL; R.B. CHURCH: "Embryo manipulation and gene transfer in domestic animals"
 [A]  - POULTRY SCIENCE, vol. 65, no. 8, 8th August 1986, pages 1437-1444; R.M. SHUMAN et al.: "Gene transfer by avian retroviruses"
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.